Asthma
COPD
Pulmonary
Site Map
2023
February
16
Phase 3 CodeBreaK 200 trial reveals superior progression-free survival in patients with non-small cell lung cancer
PT027 shows positive results in MANDALA and DENALI Phase III trials
Uptravi (selexipag) receives FDA approval for IV use in adult patients with PAH
Rubedo Life Sciences receives funding for IPF program
Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies
IPF market report details disease scope and treatments
Airsupra (PT027) approved in the U.S. for asthma
Global bronchial thermoplasty catheter market expected to grow substantially due to increase in incidence of asthma
Arrowhead initiates phase 1/2a study of ARO-MMP7 for Treatment of IPF
PFF expands research into devastating lung disease
Pulmatrix announces patient dosed in phase 2b study of PUR1900 for treatment of ABPA in subjects with asthma
Moderna announces its RSV vaccine has met primary efficacy endpoints in older adults
Bronchoscopy market size to reach $4.22 billion in 2030
Program offers critical resources to to patients living with lung disease
Kaia Health provides digital COPD treatment with approval for prescription covering 73 million people in Germany
KalVista presents three posters
Bellerophon Therapeutics to conduct phase 3 clinical trial in China for INOpulse in fibrotic interstitial lung disease
Trial with dupilumab weekly showed positive results for EoE symptoms
Page 1 of 1